Warning: The NCBI web site requires JavaScript to function. more...
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.
Gemmill MC, Thomson S, Mossialos E.
Int J Equity Health. 2008 May 2;7:12.
Related citations
Pharmaceutical policies: effects of cap and co-payment on rational drug use.
Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A.
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017. Review.
AMCP Guide to Pharmaceutical Payment Methods.
AMCP Task Force on Drug Payment Methodologies.
J Manag Care Pharm. 2007 Oct;13(8 Suppl C):S1-39.
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM, Urmie JM, Farris KB, Doucette WR.
Res Social Adm Pharm. 2010 Jun;6(2):100-9. Epub 2010 May 7.
The impact of user charges on the consumption of drugs. Empirical evidence and economic implications.
Gerdtham UG, Johannesson M.
Pharmacoeconomics. 1996 Jun;9(6):478-83.
Efficiency and equity implications of the health care reforms.
Carr-Hill RA.
Soc Sci Med. 1994 Nov;39(9):1189-201.
Health insurance, access to prescription medicines and health outcomes in children.
Ungar WJ, Ariely R.
Expert Rev Pharmacoecon Outcomes Res. 2005 Apr;5(2):215-25.
The cost of prescription medicines to patients.
Noyce PR, Huttin C, Atella V, Brenner G, Haaijer-Ruskamp FM, Hedvall M, Mechtler R.
Health Policy. 2000 Jun;52(2):129-45.
The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.
López-Negrón L, Monsanto-Planadeball HA.
P R Health Sci J. 2006 Jun;25(2):149-53.
Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK.
Atella V, Schafheutle E, Noyce P, Hassell K.
Appl Health Econ Health Policy. 2005;4(1):23-35.
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
Goldman DP, Joyce GF, Zheng Y.
JAMA. 2007 Jul 4;298(1):61-9. Review.
Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT, Barnes J, Shea T, Coulter SL.
J Manag Care Pharm. 2006 Oct;12(8):665-76.
Pharmaceutical cost management and access to psychotropic drugs: the U.S. context.
Huskamp HA.
Int J Law Psychiatry. 2005 Sep-Oct;28(5):484-95.
Prescription drug payment policy: past, present, and future.
Gondek K.
Health Care Financ Rev. 1994 Spring;15(3):1-7.
Cost sharing for pharmaceuticals--the Swedish reimbursement system.
Jönsson B.
Pharmacoeconomics. 1996;10 Suppl 2:68-74.
[Assessment of the pharmaceutical expenditure in Hungary].
Inotai A, Merész G, Kaló Z.
Acta Pharm Hung. 2010;80(4):162-72. Hungarian.
Prescription drugs: issues of cost, coverage, and quality.
Copeland C.
EBRI Issue Brief. 1999 Apr;(208):1-21.
User charges for health services in developing countries: a review of the economic literature.
McPake B.
Soc Sci Med. 1993 Jun;36(11):1397-405. Review.
Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE, Morgan S, Hurley J, van Doorslaer E.
Health Econ. 2008 Dec;17(12):1379-92.
Out-of-pocket payments for health care in Croatia: implications for equity.
Mastilica M, Bozikov J.
Croat Med J. 1999 Jun;40(2):152-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on